Charles Russell Speechlys advises Kreos Capital and Silicon Valley Bank on £20 million growth capital investment in Mereo BioPharma
Charles Russell Speechlys have advised Kreos Capital and Silicon Valley Bank on a £20 million growth capital investment in Mereo BioPharma, a UK-based specialty bio-pharmaceutical company listed on the AIM market of the London Stock Exchange.
Mereo BioPharma was established to address the R&D and financial challenges faced by an increasing number of large pharmaceutical and biotech companies, and to optimise drug development and ensure that promising drug candidates fulfil their potential.
Mereo BioPharma announced to the market that it will use the financing to increase its operational and development flexibility.
The Charles Russell Speechlys core team comprised Chris Putt (Partner), Rossana Conti (Senior Associate), Amelly Kok (Associate) and Olivia Mackie (Associate) from our Corporate Team, and Daniel Sullivan (Partner) and Susan Mitchell (Senior Associate) from our Banking Team.”
News & Insights
Charles Russell Speechlys advises Country Court Care on refinancing
Country Court’s portfolio currently comprises 30 freehold care homes, with seven opened over the past two years.
Charles Russell Speechlys joins ELITE partner programme to help ambitious UK businesses succeed
ELITE is London Stock Exchange Group’s international business support and capital raising programme for private growth companies.
Malcolm MacDougall ranked top place in UK’s ranking for most active deal lawyer by volume
The league tables are compiled by deals announced in the first half of 2018 and which are available on Mergermarket’s deals database.
Charles Russell Speechlys ranked top place by deal value in the East of England
The results were in the recent Experian MarketIQ report, showing the firm’s total value for deals in the East of England as £1,202,000,000.